tiprankstipranks
Regenicin Inc (RGIN)
OTHER OTC:RGIN
US Market

Regenicin (RGIN) Financial Statements

4 Followers

Regenicin Financial Overview

Regenicin's market cap is currently $15.35K. The company's EPS TTM is $0; its P/E ratio is -0.02; Regenicin is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Sep 21Sep 20Sep 19Sep 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -601.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -601.00K$ -635.86K$ -511.00K$ -737.00K$ -540.00K
EBITDA$ -601.00K$ -636.00K$ -511.00K$ -737.00K$ -789.00K
Net Income$ -639.00K$ -670.60K$ -560.00K$ -758.00K$ -559.00K
Balance Sheet
Cash & Short-Term Investments$ 15.49K$ 4.61K$ 4.14K$ 5.32K$ 11.15K
Total Assets$ 15.49K$ 4.61K$ 4.14K$ 5.32K$ 56.43K
Total Debt$ 642.92K$ 602.92K$ 578.32K$ 454.57K$ 212.80K
Net Debt$ 628.35K$ 601.06K$ 576.95K$ 453.75K$ 210.10K
Total Liabilities$ 5.61M$ 5.17M$ 4.29M$ 3.73M$ 3.06M
Stockholders' Equity$ -5.60M$ -5.16M$ -4.29M$ -3.73M$ -3.00M
Cash Flow
Free Cash Flow$ -27.29K$ -24.11K$ -123.20K$ -126.86K$ -133.72K
Operating Cash Flow$ -27.29K$ -24.11K$ -123.20K$ -126.86K$ -133.72K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 40.00K$ 24.60K$ 123.75K$ 124.97K$ 117.22K
Currency in USD

Regenicin Earnings and Revenue History

Regenicin Debt to Assets

Regenicin Cash Flow

Regenicin Forecast EPS vs Actual EPS